SYLMAR, Calif.—Second Sight Medical Products (NASDAQ:EYES), developer of the Argus II Retinal Prosthesis System, has appointed David Jacques vice president of research and development.

"David has over 30 years of experience in the medical and semiconductor equipment industries. Since June 2016, he has been an important contributor as a consultant to our R&D team, so I am pleased that he has joined us full-time as we execute our R&D strategy,” stated Will McGuire, president and CEO of Second Sight.

Jacques’ experience includes senior leadership roles and consulting positions at multiple medical device companies, including Stereotaxis, Intuitive Surgical, Volcano and others.